MedStar Health 5th Annual MedStar Heart Failure Summit 2022

MedStar Health 5th Annual MedStar Heart Failure Summit 2022

+ Target Audience: cardiologist

+ Information:

Date & Location

Saturday, November 12, 2022, 7:15 AM – 4:00 PM, Virtual: Platform- On Air, Bethesda, MD

Target Audience

• Specialties – Cardiac Surgery, Cardiovascular Disease, Critical Care Medicine, Hematology, Hospice and Palliative Medicine, Internal Medicine, Medical Oncology, Palliative Medicine, Physical Medicine/ Rehabilitation, Transplant
  Professions – Non-Physician, Nurse, Nurse Practitioner, Physician, Physician Assistant, Social Worker, Student

Overview

• MedStar Health 5th Annual MedStar Heart Failure Summit 2022 This virtual symposium will review the latest in the diagnosis and management of heart failure. A special emphasis will be given to special conditions such as structural heart disease, pulmonary hypertension, infiltrative cardiomyopathies, and cardio-oncology.
• It will also provide an update on recently published heart failure guidelines, an overview of modalities for treating end-stage heart failure such as mechanical circulatory support and heart transplantation. Integration of the multidisciplinary team, including palliative care, will also be discussed.

Objectives

After completing this activity, the participant will be able to:

1. Implement the most recent ACC/AHA guidelines in the diagnosis and management of heart failure.
2. Identify the risk factors for the development of chemotherapy-related cardiac disease and discuss current recommendations for treatment.
3. Recognize special conditions in patients with heart disease including structural heart disease, pulmonary hypertension, cardio-oncology, and infiltrative diseases.
4. Identify when to refer patients for specialized diagnostics and referral to advanced heart failure specialists and palliative care providers.
5. Describe the most current modalities for treating end-stage heart failure including left ventricular assist devices (LVAD) and heart transplant.
6. Describe the evaluation of patients with suspected infiltrative cardiomyopathy and implement newly approved pharmacologic therapy for amyloidosis.
7. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with heart failure.
8. Integrate a team-based approach in the care of patients with heart failure.

+ Topics:

• Keynote Introduction and Keynote Address Patient-Centered Care in Cardiac Surgery.mp4
• Keynote Questions and Discussion.mp4
• MHFS2022_brochure.pdf
• Session 1 Introduction and Update on the Heart Failure Guidelines.mp4
• Session 1 New Frontiers in Structural Heart Disease.mp4
• Session 1 New Medical Therapies in Hypertrophic Cardiomyopathy.mp4
• Session 1 Panel Discussion.mp4
• Session 1 Ventricular Arrhythmias in Heart Failure Medical Device Catheter Therapies.mp4
• Session 2 Introduction and Cardiogenic Shock.mp4
• Session 2 Medical Innovation in Heart Transplantation.mp4
• Session 2 Panel Discussion.mp4
• Session 2 Surgical Innovation in Transplantation.mp4
• Session 2 Update in Durable Left Ventricular Assist Device (LVAD) Therapy.mp4
• Track IVA Introduction Multidisciplinary Care and Fundamentals of Nursing Care for the Heart Failure Patient.mp4
• Track IVA Panel Discussion.mp4
• Track IVA Reducing Barriers to Candidacy for AHF Therapies A Psychosocial Perspective.mp4
• Track IVA Success in Heart Failure Educating the Patient, the Caregivers, and Health Care Provider.mp4
• Track IVA The Difficult Discussions Advance Care Planning in Heart Failure and the Role of Palliative Care.mp4
• Track IVB Amyloidosis.mp4
• Track IVB ECMO and Temporary MCS for Cardiogenic Shock.mp4
• Track IVB Introduction Special Considerations in Heart Failure Management and Sarcoidosis.mp4
• Track IVB Panel Discussion.mp4
• Track IVB Update in Pulmonary Hypertension.mp4